COVID-19 – Current Pharmaceutical Developments for Cures and Prevention
Join the American Association of Pharmaceutical Scientists (AAPS) featuring ACCESS Health Chair and President William A. Haseltine for a multi-day, eight-part webinar series which explores testing and analytical approaches; how regulatory agencies and companies are making a rapid response possible; re-purposing existing drugs; and maintaining both business continuity and the global supply chain in a pandemic.
This event is complimentary for AAPS members in good standing. If you are not an AAPS member, but would like to participate in this vital conversation, please join or renew via the AAPS website before start of the session(s) you’d like to attend. The post-event recordings will be available for non-members to purchase starting May 22, 2020.
Monday, April 27
11:00 am – 12:30 pm
Session 1: Opening Session – Managing an Infectious Disease Pandemic: Historic Lessons, Current and Future Approaches, featuring ACCESS Health Chair and President William A. Haseltine
1:30 pm – 3:00 pm
Session 2: International Response – Testing and Analytical Approaches
Tuesday, April 28
11:00 am – 12:30 pm
Session 3: Regulatory Perspectives – Agency Responses and Guidance
1:30 pm – 3:00 pm
Session 4: Therapeutic and Preventive Approaches
Monday, May 11
11:00 am – 12:30 pm
Session 5: Epidemiology
1:30 pm – 3:00 pm
Session 6: Pharmaceutical Business Continuity During a Pandemic
Tuesday, May 12
11:00 am – 12:30 pm
Session 7: Preparedness Policy – How to Prepare for Emerging Infectious Disease Needs and Respond with Rapid Research Development
1:30 pm – 3:00 pm
Session 8: The Global Supply Chain – Vulnerabilities, Need for Transparency, and Building Resilience in the Supply Chain
Registration Information
AAPS Members in good standing may access this webinar series live or the post-event recordings for free.
Current Members – Register Now (Coming Soon)
Non-Members – Join Now before registering
| Full Event (8 webinars) | $1,599 |
| Single webinar | $395 |